Skip to content

BEONE MEDICINES LTD.

BEIGF ONC

CIK 0001651308

← back to feed
Revenue (TTM)
$5.36B
+40.2% YoY Q1 Apr 2026
Net Income (TTM)
$447.79M
+144.5% YoY Q1 Apr 2026
EPS Diluted (TTM)
$0.29
+140.4% YoY Q1 Apr 2026
Gross Margin
87.1%
Q1 Apr 2026
Operating Margin
9.6%
Q1 Apr 2026
Net Margin
8.4%
Q1 Apr 2026
Free Cash Flow (TTM)
−$1.01B
Q1 Apr 2026
Cash
$4.79B
Q1 Apr 2026
Total Debt
$971.77M
Q1 Apr 2026
Shares Outstanding
1.45B sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings